Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Crawl-delay: 30 |
Title | Elevating Outcomes - Elevar |
Description | A biopharmaceutical company focused on the development of oncology therapeutics and dedicated to elevating treatment experiences and outcomes for patients with limited |
Keywords | N/A |
WebSite | elevartherapeutics.com |
Host IP | 173.247.246.247 |
Location | United States |
Site | Rank |
US$11,122,008
Last updated: 2022-06-18 15:51:53
elevartherapeutics.com has Semrush global rank of 951,654. elevartherapeutics.com has an estimated worth of US$ 11,122,008, based on its estimated Ads revenue. elevartherapeutics.com receives approximately 1,283,309 unique visitors each day. Its web server is located in United States, with IP address 173.247.246.247. According to SiteAdvisor, elevartherapeutics.com is safe to visit. |
Purchase/Sale Value | US$11,122,008 |
Daily Ads Revenue | US$10,267 |
Monthly Ads Revenue | US$307,995 |
Yearly Ads Revenue | US$3,695,929 |
Daily Unique Visitors | 85,554 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
elevartherapeutics.com. | A | 1798 | IP: 173.247.246.247 |
elevartherapeutics.com. | NS | 1800 | NS Record: dns1.registrar-servers.com. |
elevartherapeutics.com. | NS | 1800 | NS Record: dns2.registrar-servers.com. |
elevartherapeutics.com. | MX | 1799 | MX Record: 0 elevartherapeutics-com.mail.protection.outlook.com. |
elevartherapeutics.com. | TXT | 1799 | TXT Record: v=spf1 include:spf.protection.outlook.com ip4:208.98.167.90 -all |
elevartherapeutics.com. | TXT | 1799 | TXT Record: adobe-idp-site-verification=fd6fdb99b143ab2d7ec484865bfd05f4244fff77dadd51015a8ba1c37f327b2d |
elevartherapeutics.com. | TXT | 300 | TXT Record: apple-domain-verification=YHjWMpnPbvEiup6x |
elevartherapeutics.com. | TXT | 1799 | TXT Record: atlassian-domain-verification=XGCpAOmU5EvRMDlETdCDUiHa1FnasmAPVlQZlqHkL/99/UuaWojZt26V5szZmiJA |
elevartherapeutics.com. | TXT | 1799 | TXT Record: google-site-verification=M880AYqy_-3SbJGlWb4BL215Lqkz1psqPIpqDbfeqeQ |
Home Company Leadership Board of Directors Therapeutics Rivoceranib Apealea ® Expanded Access Program News Press Releases Publications Events Careers Contact Us Search Home Company Leadership Board of Directors Therapeutics Rivoceranib Apealea ® Expanded Access Program News Press Releases Publications Events Careers Contact Us Search Home Company Leadership Board of Directors Therapeutics Rivoceranib Apealea ® Expanded Access Program News Press Releases Publications Events Careers Contact Us Elevating Outcomes We take a relentless and inventive approach towards developing and advancing next generation therapies. ELEVAR THERAPEUTICS Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options. Our experience is rooted in oncology, and we apply the same rigor and diligence that comes with this knowledge to identifying and developing |
HTTP/1.1 406 Not Acceptable Date: Fri, 22 Oct 2021 15:25:39 GMT Server: Apache Content-Type: text/html; charset=iso-8859-1 |
Domain Name: ELEVARTHERAPEUTICS.COM Registry Domain ID: 2417205838_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.namecheap.com Registrar URL: http://www.namecheap.com Updated Date: 2021-06-26T06:23:32Z Creation Date: 2019-07-26T19:38:04Z Registry Expiry Date: 2022-07-26T19:38:04Z Registrar: NameCheap, Inc. Registrar IANA ID: 1068 Registrar Abuse Contact Email: abuse@namecheap.com Registrar Abuse Contact Phone: +1.6613102107 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.REGISTRAR-SERVERS.COM Name Server: DNS2.REGISTRAR-SERVERS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T05:49:07Z <<< |